Literature DB >> 67353

Oral treatment of carnitine myopathy.

G P Hosking, N P Cavanagh, D P Smyth, J Wilson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 67353     DOI： 10.1016/s0140-6736(77)92796-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Successful carnitine treatment in a non-carnitine-deficient lipid storage myopathy.

Authors:  R C Sengers; J A Bakkeren; J M Trijbels; A M Stadhouders; G J Egberink; H J ter Laak; H J Jaspar
Journal:  Eur J Pediatr       Date:  1980-12       Impact factor: 3.183

2.  Mitochondrial myopathies: disorders of the respiratory chain and oxidative phosphorylation.

Authors:  J B Clark; D J Hayes; J A Morgan-Hughes; E Byrne
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

3.  Functional evaluation of Duchenne muscular dystrophy: proposal for a protocol.

Authors:  F Cornelio; F Dworzak; L Morandi; E Fedrizzi; M R Balestrini; L Gondoni
Journal:  Ital J Neurol Sci       Date:  1982-12

4.  EMG changes in chronically dialyzed uraemic subjects undergoing d, 1-Carnitine treatment.

Authors:  P M Rossini; L Marchionno; D Gambi; M Pirchio; G Del Rosso; A Albertazzi
Journal:  Ital J Neurol Sci       Date:  1981-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.